Nonclinical Evaluation Support
for Companion Animal Development
Before moving into dog or cat studies, KGAH-ONE helps organize development hypotheses, mechanism of action, endpoints, biomarkers, candidate selection, and Go / No-Go criteria, then connects the program with suitable nonclinical models and analytical partners.
KGAH-ONE is not a single study-menu sales window. It is a coordination platform for designing what should be evaluated, in what order, and with which specialized partner in Animal Health development.
KGAH-ONE designs development decision pathways, not just study menus.
For companion animal drugs, medical technologies, and functional products, studies in the species where the product will ultimately be used are essential. But if mechanism, endpoints, biomarkers, candidate selection, dose, or timing are still unclear before those studies begin, later results can become difficult to interpret.
KGAH-ONE helps organize the development question and, where appropriate, coordinates with specialized partners such as SMC Laboratories for nonclinical evaluation, pathology analysis, model selection, and endpoint planning.
Development Question
What needs to be clarified before moving into dog or cat studies?
KGAH-ONE
MoA, endpoints, biomarkers, candidate selection, Go / No-Go, partner design
Specialized Partners
Disease models, pathology, tissue analysis, molecular readouts, business support
Why use mouse nonclinical evaluation before dog or cat studies?
Mouse studies do not replace dog or cat studies. They help make later dog or cat studies more interpretable by clarifying mechanism, endpoints, biomarkers, candidate priorities, and Go / No-Go criteria before moving forward.
Nonclinical Evaluation Support Areas
The areas below are representative examples of what KGAH-ONE can help organize and connect. The goal is not to list individual models, but to combine models, pathology, endpoints, biomarkers, and specialized partners according to each development question.
Renal and CKD Evaluation Support
For feline CKD and related renal programs, we help organize renal function, tubular injury, inflammation, fibrosis, tissue change, and biomarker readouts before dog or cat studies.
- Adenine-induced CKD model
- Renal function / BUN / Creatinine
- PAS / Sirius Red / fibrosis assessment
- Candidate prioritization / Go-No Go
Cancer and Immuno-Oncology Evaluation Support
Beyond tumor shrinkage, nonclinical studies can help evaluate tumor microenvironment, immune cell infiltration, checkpoint pathways, cytokines, gene expression, and combination rationale.
- Xenograft / humanized mouse options
- PD-1 / PD-L1 / CTLA-4-related evaluation
- IHC / immune cell profiling
- Combination strategy support
Pathology and Tissue-Level Analysis
Blood data and clinical observations may not fully explain what is happening in tissues. Tissue-level analysis can help confirm efficacy, safety, and mechanism of action.
- Histopathology / quantitative pathology
- IHC / staining / image analysis
- Efficacy / safety / MoA confirmation
- Report for development decision
Inflammation and Fibrosis Model Evaluation
For chronic inflammation, fibrosis, arthritis, skin, lung, liver, or kidney-related programs, KGAH-ONE can help match disease biology with suitable models and tissue readouts.
- CAIA / inflammatory models
- Fibrosis-related models
- Histology and biomarker readouts
- Anti-inflammatory / anti-fibrotic evaluation
Model Selection and Endpoint Planning
Rather than asking which model is available, we begin with what must be clarified before dog or cat studies, then design the model, endpoints, and analytical approach accordingly.
- Development hypothesis design
- Endpoint / biomarker planning
- Dose / timing / candidate comparison
- Go / No-Go criteria
Custom Evaluation and Partner Coordination
In addition to existing models, KGAH-ONE can help combine evaluation systems, analytical items, and specialized partners according to the program’s development objective.
- Specialized partner coordination
- Scientific and business pathway design
- Nonclinical evaluation planning
- Follow-on study discussion
Representative Models and Analytical Approaches
The examples below are not exhaustive. Actual evaluation plans should be designed around the target disease, mechanism, candidate modality, and expected endpoints in future dog or cat studies.
Adenine CKD
Renal injury, inflammation, fibrosis, renal function, histopathology, and biomarkers can support candidate selection and endpoint planning before feline CKD studies.
Xenograft / IO
Tumor growth, IHC, immune cell infiltration, cytokines, and gene expression can help organize cancer immunotherapy and combination hypotheses.
Pathology Analysis
Tissue-level evidence can help explain response or non-response that may not be clear from clinical signs or blood data alone.
Models and analyses shown here are representative examples. KGAH-ONE combines evaluation pathways and specialized partners according to each development question.
Before moving into dog or cat studies, organize the nonclinical evaluation pathway.
KGAH-ONE helps Animal Health companies organize development questions and connect them with suitable nonclinical evaluation, pathology, model selection, and specialized partner coordination.
KGAH-ONE is an Animal Health intelligence and partner coordination platform of Kawasaki Global Animal Health, Inc. Specialized nonclinical evaluation and scientific support may be provided by partners such as SMC Laboratories, depending on the development question.